Benefits of utilizing gene-modified iPSCs for clinical applications

James Ellis*, Christopher Baum, Nissim Benvenisty, Gustavo Mostoslavsky, Hideyuki Okano, William L. Stanford, Matthew Porteus, Michel Sadelain

*Corresponding author for this work

Research output: Contribution to journalLetterpeer-review

19 Scopus citations
Original languageAmerican English
Pages (from-to)429-430
Number of pages2
JournalCell Stem Cell
Issue number4
StatePublished - 8 Oct 2010

Cite this